Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Study completedNCT00094484
What this trial is testing

Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis

Who this might be right for
Kidney DiseaseChronic Kidney Disease
Amgen 400
Post-approval studies (Phase 4)Study completedNCT00717067
What this trial is testing

Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
ViiV Healthcare 30
Testing effectiveness (Phase 2)Study completedNCT00530114
What this trial is testing

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

Who this might be right for
End Stage Renal DiseaseChronic Kidney DiseaseHyperphosphatemic+1 more
Amgen 167
Early research (Phase 1)Study completedNCT06775834
What this trial is testing

Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd. 24
Not applicableStudy completedNCT00784381
What this trial is testing

Computer Prescribing System and Impaired Renal Function

Who this might be right for
Impaired Renal Function
Assistance Publique - Hôpitaux de Paris 12
Early research (Phase 1)Study completedNCT03165071
What this trial is testing

Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease

Who this might be right for
Severe Renal ImpairmentHealthy Subjects
Idorsia Pharmaceuticals Ltd. 16
Testing effectiveness (Phase 2)WithdrawnNCT02397395
What this trial is testing

An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.

Who this might be right for
Renal ImpairmentEnd-stage Renal Disease
Janssen R&D Ireland
Early research (Phase 1)Study completedNCT02289703
What this trial is testing

A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis

Who this might be right for
End-Stage Renal Disease
Janssen Research & Development, LLC 16
Large-scale testing (Phase 3)Study completedNCT01879618
What this trial is testing

Use Of Fragmin In Hemodialysis

Who this might be right for
Chronic Renal Failure
Pfizer 152
Early research (Phase 1)Study completedNCT00358813
What this trial is testing

Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment

Who this might be right for
Vomiting
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT07033182
What this trial is testing

Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment

Who this might be right for
Infections Caused by Anaerobic BacteriaRenal Impairment
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd 24
Early research (Phase 1)Study completedNCT06380153
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 26
Early research (Phase 1)Study completedNCT02536937
What this trial is testing

The Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Who this might be right for
Gaucher Disease
Sanofi 32
Early research (Phase 1)Study completedNCT02281422
What this trial is testing

An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093

Who this might be right for
Epilepsy
Bial - Portela C S.A. 40
Large-scale testing (Phase 3)Ended earlyNCT04064827
What this trial is testing

Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)
AbbVie 2
Early research (Phase 1)Study completedNCT06613763
What this trial is testing

RAY1225 in Participants With Impaired Kidney Function

Who this might be right for
Kidney Impairment
Guangdong Raynovent Biotech Co., Ltd 32
Early research (Phase 1)Study completedNCT02400307
What this trial is testing

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

Who this might be right for
HIV
Gilead Sciences 19